Holen Sie sich die Stockscreener-App
34.02
0.53%
-0.18
Handel nachbörslich:
33.90
-0.12
-0.35%
Schlusskurs vom Vortag:
$34.20
Offen:
$34.36
24-Stunden-Volumen:
781.10K
Relative Volume:
1.08
Marktkapitalisierung:
$1.49B
Einnahmen:
$596.57M
Nettoeinkommen (Verlust:
$-109.88M
KGV:
-8.7814
EPS:
-3.8741
Netto-Cashflow:
$28.72M
1W Leistung:
+2.35%
1M Leistung:
+2.44%
6M Leistung:
+55.63%
1J Leistung:
+18.33%
1-Tages-Spanne:
$33.67
$34.39
1-Wochen-Bereich:
$33.10
$34.88
52-Wochen-Spanne:
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
34.02 | 1.49B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Bestätigt | Needham | Buy |
| 2025-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2025-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action InvestigationAZTA - Business Wire
Azenta faces securities fraud probe after CEO r... - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc.AZTA - prnewswire.com
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta, Inc. (AZTA) Options Chain - Yahoo! Finance Canada
Tax withholding reduces Azenta (NASDAQ: AZTA) CEO stake - Stock Titan
Azenta, Inc. (AZTA) Investor Outlook: Analyzing Growth Potential Amidst A 4.44% Upside - DirectorsTalk Interviews
Azenta Inc. (AZTA) Slips to $33.24 as Shares Test Key Support ZoneSymmetrical Triangle - siam.in
Azenta formalizes interim CEO pay and retention grants - The Globe and Mail
Azenta sets compensation terms for interim CEO and grants executive retention awards - Investing.com
Form 8K Azenta Inc For: 17 September By Investing.com - Investing.com UK
Azenta (NASDAQ: AZTA) Grants 15,272 Shares to Multiomics President Martin William E. III - Kalkine Media
Azenta (NASDAQ: AZTA) Grants Interim CEO Madaus Martin D 36,653 Shares at No Cost - Kalkine Media
Azenta (AZTA) interim CEO gets new year-long stock grant - Stock Titan
Azenta (AZTA) grants 4,586 stock units to accounting VP - Stock Titan
Azenta, Inc. (AZTA) awards 15,272 stock units to its top lawyer - Stock Titan
Azenta Inc. (AZTA) Steadies Near $30.17 as Traders Watch $31.68 ResistanceDouble Top - dars.gov.et
Azenta, Inc. (AZTA) accounting chief reports owning no stock - Stock Titan
Azenta (NASDAQ: AZTA) Secures Early $35M Vendor Loan Repayment, Finalizing $63M Cash Purchase - Kalkine Media
Azenta Completes B Medical Divestiture With Loan Repayment - theglobeandmail.com
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems - PR Newswire
AZTA Q2 2026 Earnings: EPS of $0.16 Beats Estimates by 37.8% While Shares Slip 1.96%ROE Trend Analysis - dars.gov.et
Azenta CEO resignation sparks 12% stock drop am... - Pluang
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - The Globe and Mail
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
Azenta appoints interim CEO as John Marotta resigns - Investing.com India
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - theglobeandmail.com
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Azenta (AZTA) Holds Steady at $33.39 as Shares Trade Mid-Range Between Support and ResistanceChart Pattern Alerts - dars.gov.et
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):